Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 4,865.45
-3.90 (-0.08%)
At close: Mar 5, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 80.76 billion as of March 5, 2026. Its market cap has decreased by -9.31% in one year.
Market Cap
80.76B
Enterprise Value
77.96B
Revenue
13.49B
Ranking
n/a
PE Ratio
27.55
Stock Price
4,865.45
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 80.76B, an increase of 728.70%. That is a compound annual growth rate of 8.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 80.76B | -14.66% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 214.90B |
| Granules India | 142.19B |
| Jubilant Pharmova | 132.60B |
| Caplin Point Laboratories | 125.01B |
| Rubicon Research | 123.82B |
| CORONA Remedies | 95.72B |
| Viyash Scientific | 88.18B |
| Sanofi India | 87.75B |